157 related articles for article (PubMed ID: 34216185)
1. The Lab4P Consortium of Probiotics Attenuates Atherosclerosis in LDL Receptor Deficient Mice Fed a High Fat Diet and Causes Plaque Stabilization by Inhibiting Inflammation and Several Pro-Atherogenic Processes.
O'Morain VL; Chan YH; Williams JO; Alotibi R; Alahmadi A; Rodrigues NP; Plummer SF; Hughes TR; Michael DR; Ramji DP
Mol Nutr Food Res; 2021 Sep; 65(17):e2100214. PubMed ID: 34216185
[TBL] [Abstract][Full Text] [Related]
2. (+)-Catechin Attenuates Multiple Atherosclerosis-Associated Processes In Vitro, Modulates Disease-Associated Risk Factors in C57BL/6J Mice and Reduces Atherogenesis in LDL Receptor Deficient Mice by Inhibiting Inflammation and Increasing Markers of Plaque Stability.
Chan YH; Moss JWE; Williams JO; Ferekidis N; Alshehri N; Hughes TR; Menendez-Gonzalez JB; Plummer SF; Michael DR; Rodrigues NP; Ramji DP
Mol Nutr Food Res; 2023 Jul; 67(14):e2200716. PubMed ID: 37150886
[TBL] [Abstract][Full Text] [Related]
3. Orp8 deficiency in bone marrow-derived cells reduces atherosclerotic lesion progression in LDL receptor knockout mice.
van Kampen E; Beaslas O; Hildebrand RB; Lammers B; Van Berkel TJ; Olkkonen VM; Van Eck M
PLoS One; 2014; 9(10):e109024. PubMed ID: 25347070
[TBL] [Abstract][Full Text] [Related]
4. P2X
Peikert A; König S; Suchanek D; Rofa K; Schäfer I; Dimanski D; Karnbrock L; Bulatova K; Engelmann J; Hoppe N; Wadle C; Heidt T; Albrecht P; von Garlen S; Härdtner C; Hilgendorf I; Wolf D; von Zur Mühlen C; Bode C; Zirlik A; Duerschmied D; Merz J; Stachon P
Sci Rep; 2022 Feb; 12(1):2801. PubMed ID: 35181718
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
[TBL] [Abstract][Full Text] [Related]
6. Absence of gravin-mediated signaling inhibits development of high-fat diet-induced hyperlipidemia and atherosclerosis.
Fan Q; Yin X; Rababa'h A; Diaz Diaz A; Wijaya CS; Singh S; Suryavanshi SV; Vo HH; Saeed M; Zhang Y; McConnell BK
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H793-H810. PubMed ID: 31441691
[TBL] [Abstract][Full Text] [Related]
7. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice.
Willecke F; Yuan C; Oka K; Chan L; Hu Y; Barnhart S; Bornfeldt KE; Goldberg IJ; Fisher EA
PLoS One; 2015; 10(6):e0128996. PubMed ID: 26046657
[TBL] [Abstract][Full Text] [Related]
8. The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice.
Michael DR; Davies TS; Moss JWE; Calvente DL; Ramji DP; Marchesi JR; Pechlivanis A; Plummer SF; Hughes TR
Sci Rep; 2017 Jun; 7(1):2883. PubMed ID: 28588193
[TBL] [Abstract][Full Text] [Related]
9. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
[TBL] [Abstract][Full Text] [Related]
10. Pro-atherogenic actions of signal transducer and activator of transcription 1 serine 727 phosphorylation in LDL receptor deficient mice via modulation of plaque inflammation.
Al-Ahmadi W; Webberley TS; Joseph A; Harris F; Chan YH; Alotibi R; Williams JO; Alahmadi A; Decker T; Hughes TR; Ramji DP
FASEB J; 2021 Oct; 35(10):e21892. PubMed ID: 34569651
[TBL] [Abstract][Full Text] [Related]
11. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor necrosis factor-α therapy increases plaque burden in a mouse model of experimental atherosclerosis.
Oberoi R; Vlacil AK; Schuett J; Schösser F; Schuett H; Tietge UJF; Schieffer B; Grote K
Atherosclerosis; 2018 Oct; 277():80-89. PubMed ID: 30176568
[TBL] [Abstract][Full Text] [Related]
13. Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro.
O'Morain VL; Chen J; Plummer SF; Michael DR; Ramji DP
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835055
[TBL] [Abstract][Full Text] [Related]
14. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
16. The role of heat shock protein 90 in migration and proliferation of vascular smooth muscle cells in the development of atherosclerosis.
Kim J; Jang SW; Park E; Oh M; Park S; Ko J
J Mol Cell Cardiol; 2014 Jul; 72():157-67. PubMed ID: 24650873
[TBL] [Abstract][Full Text] [Related]
17. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
Yu P; Qian AS; Chathely KM; Trigatti BL
Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
[TBL] [Abstract][Full Text] [Related]
18. Addition of fish oil to atherogenic high fat diet inhibited atherogenesis while olive oil did not, in LDL receptor KO mice.
Harari A; Leikin Frenkel A; Barshack I; Sagee A; Cohen H; Kamari Y; Harats D; Kandel Kfir M; Shaish A
Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):709-716. PubMed ID: 32007335
[TBL] [Abstract][Full Text] [Related]
19. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.
Bi X; Zhu X; Gao C; Shewale S; Cao Q; Liu M; Boudyguina E; Gebre AK; Wilson MD; Brown AL; Parks JS
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1888-99. PubMed ID: 24833800
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of experimental atherosclerosis by interleukin-19.
Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
